Value through Innovation19 September 2016

Our Mission

We will improve the health and well being of people and animals through being a part of an independent, innovative, research and development driven company. Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Click here for our Global Vision.

Inspiration Magazine 2

Inspiration - our second magazine dedicated to Idiopathic Pulmonary Fibrosis. Produced in partnership with Action for Pulmonary Fibrosis and the British Lung Foundation.

Inspiration

Inspiration Magazine

Inspiration - special magazine dedicated to Idiopathic Pulmonary Fibrosis. Produced in partnership with Action for Pulmonary Fibrosis and the British Lung Foundation.

Inspiration


Atrial Fibrillation Infographic 

Learn about atrial fibrillation and preventing stroke in your area

Empowering carers within the healthcare industry

Learn more about Pharmaphorum and Boehringer Ingelheim's White paper

Facts about us

Facts about us

We are one of the top 20 leading pharmaceutical companies in the world.

In 2014, worldwide, we had sales of €13.3 billion; while spending 19.9% of net sales in our largest business segment Prescription Medicines on research and development.

Our key areas of interest are: respiratory disease, cardiovascular disease, HIV, Parkinson's disease, thromboembolic disease, cerebrovascular disease, diabetes and oncology.

Learn more

Conditions

Community Spirit

Careers